Skip to main content
Find more clinical trials

RVT-101 for Dementia with Lewy Bodies (HEADWAY-DLB)

Start: January 2016
End: December 2017
Enrollment: 240

What Is This Study About?

Researchers will test the efficacy and safety of the experimental drug RVT-101 in people with dementia with Lewy bodies, including its effect on visual hallucinations.

Do I Qualify To Participate in This Study?

Minimum Age: 50 Years

Maximum Age: 85 Years

Must have:

  • Probable dementia with Lewy bodies
  • Mini-Mental State Examination score of 14-26 inclusive
  • Ability to comply with procedures for cognitive and other testing
  • Reliable caregiver who can report on participant's status throughout study

Must NOT have:

  • Atypical clinical features or clinical course that suggest diagnosis other than dementia with Lewy bodies
  • Any clinically relevant disease that makes the patient unsuitable for the study
 

Who Is the General Study Contact?

For more information about this trial, contact Axovant Clinical Trials at 1-646-677-5778.

Study Contact
Axovant Clinical Trials

Need Help?

Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.

Where Is This Study Located?

Arizona
US138
Phoenix, AZ 85006
US108
Phoenix, AZ 85013
US139
Sun City, AZ 85351
US125
Tucson, AZ 85704
California
US119
Irvine, CA 92868
US134
Oxnard, CA 93030
US133
Rancho Mirage, CA 92270
US140
Sacramento, CA 95816
Colorado
US141
Englewood, CO 80113
District of Columbia
US123
Washington, DC 20007
Florida
US104
Boca Raton, FL 33431
US116
Boca Raton, FL 33486
US111
Jacksonville, FL 32224
US122
Orlando, FL 32806
US137
Palm Beach Gardens, FL 33410
US126
Tampa, FL 33609
Georgia
US136
Atlanta, GA 30331
Illinois
US112
Chicago, IL 60612
Indiana
US118
Indianapolis, IN 46202
Kentucky
US105
Lexington, KY 40536
Massachusetts
US135
Newton, MA 02459
US130
Quincy, MA 02196
Minnesota
US102
Rochester, MN 55905
New York
US109
New York, NY 10032
North Carolina
US100
Chapel Hill, NC 27514
Ohio
US110
Cleveland, OH 44195
US106
Columbus, OH 43210
Oregon
US131
Portland, OR 97210
Pennsylvania
US120
Willow Grove, PA 19090
Texas
US124
Dallas, TX 75390
Virginia
US101
Charlottesville, VA 22908

Who Sponsors This Study?

Lead: Axovant Sciences Ltd.

Source: ClinicalTrials.gov ID: NCT02669433